Apollomics director receives option for 8,000 shares

The COO's 8,000-share option vests in two 50% installments, contingent on continued service through each vesting date.

This filing corrects an earlier one, and you can read the original Form 4 if you want to see what changed.

Rhea-AI Filing Summary

Apollomics Inc. director and Chief Operating Officer Chen Yi-Kuei reported that 5,000 restricted stock units vested on September 15, 2026, corresponding to 5,000 Class A ordinary shares. Reported direct holdings after the transaction were 20,100 shares; that amount includes a 100-share adjustment for previously owned shares that had been omitted.

On September 14, 2026, Chen received an option covering 8,000 shares, with a $23.18 exercise price and a September 14, 2036 expiration date. The option vests in two installments, subject to continued service through each vesting date. The reported indirect holding through Maxpro Investment Co., Ltd. was 121,248 Class A ordinary shares.

Insider Trade Summary

5,000 shares exercised/converted

Exercise 4 txns

Insider Chen Yi-Kuei

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units F4, F5	5,000	$0.00	$0.00
Exercise	CLASS A ORDINARY SHARES F1	5,000	$0.00	$0.00
Grant/Award	Stock Option (Right to Buy) F3	8,000	$0.00	$0.00
holding	CLASS A ORDINARY SHARES F2	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 8,000 contracts (Direct); Restricted Stock Units — 5,000 contracts (Direct); CLASS A ORDINARY SHARES — 20,100 shares (Direct); CLASS A ORDINARY SHARES — 121,248 shares (Indirect, Through Maxpro Investment Co., Ltd.)

Footnotes (5)

1. F1. The amount reported includes a 100 share adjustment for shares previously owned but inadvertently omitted.
2. F2. The reporting person is a member of the Board of Directors of Maxpro Investment Co., Ltd. and is co-founder and managing director of Maxpro Ventures Ltd. Excludes 3,823 Class A Ordinary Shares issuable upon the exercise of warrants held directly by Maxpro Investment Co., Ltd., which were previously reported on the Form 3 filed March 18, 2026 and the Form 3/A filed April 14, 2026. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
3. F3. The stock option was granted under the Apollomics Inc. 2023 Incentive Award Plan on September 14, 2026. The option vests and becomes exercisable over a one-year period: fifty percent (50%) of the shares subject to the option vest on March 14, 2027 (six months from the grant date), and the remaining fifty percent (50%) vest on September 14, 2027 (twelve months from the grant date), subject to the reporting person's continued service to the Issuer through each applicable vesting date.
4. F4. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share
5. F5. RSUs were granted and previously reported on a Form 3 filed March 18, 2026 and a Form 3/A filed April 14, 2026. Of the initial RSU grant, 5,000 shares vested on each of February 9, 2026, March 15, 2026, June 15, 2026 and September 15, 2026. This transaction represents the vesting of 5,000 RSUs on September 15, 2026.

Key Figures

Restricted stock units vested: 5,000 RSUs Class A ordinary shares acquired: 5,000 shares Direct shares after transaction: 20,100 shares +4 more

7 metrics

Restricted stock units vested 5,000 RSUs September 15, 2026

Class A ordinary shares acquired 5,000 shares Upon vesting on September 15, 2026

Direct shares after transaction 20,100 shares Includes a 100-share adjustment for previously owned shares omitted from the prior report

Option grant 8,000 shares Granted September 14, 2026

Option exercise price $23.18 per share Option granted September 14, 2026

Option expiration date September 14, 2036 Expiration date corrected in the amended report

Indirect shares held through Maxpro 121,248 Class A ordinary shares Held through Maxpro Investment Co., Ltd.

Key Terms

Restricted Stock Units, contingent right, vests and becomes exercisable, pecuniary interest, +1 more

5 terms

Restricted Stock Units financial

"Restricted Stock Units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"a contingent right to receive one Class A Ordinary Share"

vests and becomes exercisable financial

"vests and becomes exercisable over a one-year period"

pecuniary interest financial

"except to the extent of his pecuniary interest therein"

2023 Incentive Award Plan financial

"under the Apollomics Inc. 2023 Incentive Award Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many APLM shares did Chen Yi-Kuei hold through Maxpro?

Chen Yi-Kuei reported 121,248 Class A ordinary shares held indirectly through Maxpro Investment Co., Ltd. The footnote identifies him as a member of Maxpro Investment Co., Ltd.'s board and as co-founder and managing director of Maxpro Ventures Ltd.

What are the vesting terms of the APLM option grant?

The 8,000-share option vests 50% on March 14, 2027, and the remaining 50% on September 14, 2027, subject to Chen Yi-Kuei's continued service through each applicable vesting date.

Was Chen Yi-Kuei's APLM transaction reported under a Rule 10b5-1 plan?

No Rule 10b5-1 plan is reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/24/2026 - 07:55 PM Accepted by SEC EDGAR 09/24/2026 - 07:54 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chen Yi-Kuei

(Last) (First) (Middle)

668 ARROW GRAND CIR. SUITE 206

(Street)

COVINA CALIFORNIA 91772

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Apollomics Inc. [ APLM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
09/17/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
CLASS A ORDINARY SHARES	09/15/2026		M		5,000	A	$0	20,100	D(1)
CLASS A ORDINARY SHARES								121,248	I	Through Maxpro Investment Co., Ltd.(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$23.18	09/14/2026		A		8,000		(3)	09/14/2036	CLASS A ORDINARY SHARES	8,000	$0	8,000	D
Restricted Stock Units	(4)	09/15/2026		M			5,000	(5)	(5)	CLASS A ORDINARY SHARES	5,000	$0	5,000	D

Explanation of Responses:

1. The amount reported includes a 100 share adjustment for shares previously owned but inadvertently omitted.

2. The reporting person is a member of the Board of Directors of Maxpro Investment Co., Ltd. and is co-founder and managing director of Maxpro Ventures Ltd. Excludes 3,823 Class A Ordinary Shares issuable upon the exercise of warrants held directly by Maxpro Investment Co., Ltd., which were previously reported on the Form 3 filed March 18, 2026 and the Form 3/A filed April 14, 2026. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

3. The stock option was granted under the Apollomics Inc. 2023 Incentive Award Plan on September 14, 2026. The option vests and becomes exercisable over a one-year period: fifty percent (50%) of the shares subject to the option vest on March 14, 2027 (six months from the grant date), and the remaining fifty percent (50%) vest on September 14, 2027 (twelve months from the grant date), subject to the reporting person's continued service to the Issuer through each applicable vesting date.

4. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share

5. RSUs were granted and previously reported on a Form 3 filed March 18, 2026 and a Form 3/A filed April 14, 2026. Of the initial RSU grant, 5,000 shares vested on each of February 9, 2026, March 15, 2026, June 15, 2026 and September 15, 2026. This transaction represents the vesting of 5,000 RSUs on September 15, 2026.

Remarks:

This Form 4 is being amended to correct the expiration date of the stock option and clarify the ownership of shares now discussed in footnote (1).

	/s/ Alison M. Pear, Attorney-In-Fact	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)